Life Sciences Third Party Contracts Representations and Warranties Clause

Summary

This Life Sciences Third Party Contracts Representations and Warranties Clause supplements a generic material contracts representation and requires disclosure from a target of material third party contracts relating to clinical R&D, distribution, supply, manufacturing, marketing, and collaborative development of drug products and biologics. This template includes practical guidance, drafting notes, and alternate clauses. For detailed guidance on life sciences transactions, see Life Sciences M&A Transactions and Life Sciences Corporate Transactions Resource Kit. See also these annotated clauses: • Life Sciences FDA Matters Representation and Warranty Clause • Life Sciences Purchase Price Inventory Adjustment Clause • Life Sciences Inventory Count Clause • Life Sciences Inventory / Sufficiency of Assets Representation and Warranty Clause • Life Sciences Medical Device FDA Matters Representation and Warranty Clause • Life Sciences Milestone Based Earn-Out Clause (EU) • Life Sciences Net Sales Based Earn-Out Clause • Life Sciences Post-Closing Accounts Receivable Covenant Clause • Life Sciences Post-Closing Price Reporting Covenant Clause • Life Sciences Post-Closing Regulatory Covenant Clause • Life Sciences Post-Closing Transitional Brand License Clause • Life Sciences Post-Closing Transition Covenant Clause • Life Sciences Product Approval Representation and Warranty Clause • Life Sciences Product Liability Representation and Warranty Clause • Life Sciences Sales / Net Revenue Based Earn-Out Clause • Life Sciences Survival Clause • Life Sciences Working Capital Adjustment Clause